Novo Nordisk (Denmark) Price History
| NOVO-B Stock | DKK 862.70 8.60 0.99% |
If you're considering investing in Novo Stock, it is important to understand the factors that can impact its price. As of today, the current price of Novo Nordisk stands at 862.70, as last reported on the 18th of April 2024, with the highest price reaching 877.00 and the lowest price hitting 858.00 during the day. Novo Nordisk appears to be very steady, given 3 months investment horizon. Novo Nordisk AS has Sharpe Ratio of 0.16, which conveys that the firm had a 0.16% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Novo Nordisk, which you can use to evaluate the volatility of the firm. Please exercise Novo Nordisk's Downside Deviation of 1.28, mean deviation of 1.25, and Risk Adjusted Performance of 0.115 to check out if our risk estimates are consistent with your expectations.
Novo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Novo |
Sharpe Ratio = 0.1602
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NOVO-B | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.82 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Novo Nordisk is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novo Nordisk by adding it to a well-diversified portfolio.
Novo Nordisk Stock Price History Chart
There are several ways to analyze Novo Stock price data. The simplest method is using a basic Novo candlestick price chart, which shows Novo Nordisk price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 14, 2024 | 917.88 |
| Lowest Price | January 23, 2024 | 715.94 |
Novo Nordisk April 18, 2024 Stock Price Synopsis
Various analyses of Novo Nordisk's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Novo Stock. It can be used to describe the percentage change in the price of Novo Nordisk from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Novo Stock.| Novo Nordisk Price Rate Of Daily Change | 0.99 | |
| Novo Nordisk Price Action Indicator | (9.10) | |
| Novo Nordisk Price Daily Balance Of Power | (0.45) | |
| Novo Nordisk Accumulation Distribution | 49,772 |
Novo Nordisk April 18, 2024 Stock Price Analysis
Novo Stock Price History Data
The price series of Novo Nordisk for the period between Fri, Jan 19, 2024 and Thu, Apr 18, 2024 has a statistical range of 201.94 with a coefficient of variation of 7.4. The daily prices for the period are spread out with arithmetic mean of 830.5. The median price for the last 90 days is 844.81. The company underwent 1:2 stock split on 13th of September 2023. Novo Nordisk AS issued dividends to stockholders on 2022-08-12.| Open | High | Low | Close | Volume | ||
| 04/18/2024 | 874.90 | 877.00 | 858.00 | 862.70 | 2,297,378 | |
| 04/17/2024 | 864.40 | 879.40 | 861.60 | 871.30 | 1,469,864 | |
| 04/16/2024 | 862.00 | 872.10 | 854.70 | 867.50 | 1,728,440 | |
| 04/15/2024 | 879.00 | 888.00 | 876.00 | 879.20 | 1,814,804 | |
| 04/12/2024 | 870.00 | 891.90 | 868.60 | 880.00 | 2,064,983 | |
| 04/11/2024 | 856.60 | 873.50 | 856.50 | 869.30 | 2,276,825 | |
| 04/10/2024 | 857.00 | 866.00 | 845.10 | 866.00 | 1,708,836 | |
| 04/09/2024 | 875.00 | 877.90 | 856.40 | 857.70 | 1,941,371 | |
| 04/08/2024 | 865.50 | 874.90 | 862.80 | 871.60 | 1,598,241 | |
| 04/05/2024 | 856.50 | 870.00 | 848.80 | 867.50 | 2,774,129 | |
| 04/04/2024 | 871.70 | 874.30 | 859.00 | 860.60 | 2,161,343 | |
| 04/03/2024 | 876.00 | 882.10 | 865.20 | 878.80 | 2,111,473 | |
| 04/02/2024 | 897.30 | 898.00 | 859.40 | 867.10 | 3,727,558 | |
| 03/27/2024 | 895.00 | 896.30 | 877.60 | 881.30 | 2,544,307 | |
| 03/26/2024 | 890.40 | 894.60 | 879.00 | 888.30 | 2,930,730 | |
| 03/25/2024 | 890.00 | 895.40 | 884.50 | 894.50 | 1,462,573 | |
| 03/22/2024 | 888.40 | 896.70 | 883.10 | 887.20 | 2,198,005 | |
| 03/21/2024 | 892.30 | 898.90 | 870.10 | 887.50 | 3,529,581 | |
| 03/20/2024 | 900.90 | 903.90 | 895.54 | 895.54 | 1,802,876 | |
| 03/19/2024 | 913.40 | 918.10 | 890.78 | 890.78 | 3,180,749 | |
| 03/18/2024 | 908.00 | 914.20 | 896.80 | 907.65 | 2,038,452 | |
| 03/15/2024 | 920.00 | 924.30 | 897.53 | 897.53 | 5,984,147 | |
| 03/14/2024 | 910.60 | 927.90 | 909.20 | 917.88 | 2,484,956 | |
| 03/13/2024 | 916.70 | 923.10 | 899.02 | 899.02 | 2,335,821 | |
| 03/12/2024 | 903.00 | 919.90 | 883.50 | 908.25 | 2,504,551 | |
| 03/11/2024 | 914.40 | 921.20 | 888.69 | 888.69 | 2,679,790 | |
| 03/08/2024 | 910.00 | 919.50 | 898.52 | 898.52 | 3,981,718 | |
| 03/07/2024 | 858.40 | 932.00 | 853.50 | 913.02 | 6,905,154 | |
| 03/06/2024 | 852.60 | 856.50 | 842.82 | 842.82 | 2,164,149 | |
| 03/05/2024 | 881.20 | 883.30 | 848.88 | 848.88 | 2,966,373 | |
| 03/04/2024 | 858.80 | 880.90 | 858.30 | 870.92 | 3,392,631 | |
| 03/01/2024 | 819.80 | 850.90 | 817.10 | 844.81 | 3,411,569 | |
| 02/29/2024 | 838.50 | 838.50 | 813.83 | 813.83 | 5,761,952 | |
| 02/28/2024 | 827.00 | 842.60 | 827.00 | 828.13 | 1,684,926 | |
| 02/27/2024 | 849.10 | 852.00 | 806.50 | 827.93 | 3,121,587 | |
| 02/26/2024 | 846.60 | 851.90 | 838.06 | 838.06 | 1,783,586 | |
| 02/23/2024 | 853.20 | 856.00 | 842.92 | 842.92 | 1,466,037 | |
| 02/22/2024 | 841.00 | 855.00 | 838.10 | 847.09 | 2,516,406 | |
| 02/21/2024 | 836.00 | 856.00 | 816.00 | 824.85 | 2,671,753 | |
| 02/20/2024 | 858.00 | 861.50 | 837.26 | 837.26 | 2,461,009 | |
| 02/19/2024 | 856.80 | 858.60 | 851.70 | 851.86 | 1,349,822 | |
| 02/16/2024 | 844.00 | 851.80 | 841.60 | 844.81 | 2,253,807 | |
| 02/15/2024 | 843.00 | 852.20 | 842.43 | 842.43 | 2,154,177 | |
| 02/14/2024 | 836.00 | 848.20 | 829.30 | 840.84 | 2,400,458 | |
| 02/13/2024 | 831.10 | 841.40 | 826.34 | 826.34 | 2,290,762 | |
| 02/12/2024 | 842.20 | 845.70 | 824.65 | 824.65 | 2,315,533 | |
| 02/09/2024 | 824.00 | 833.50 | 819.30 | 825.94 | 2,191,243 | |
| 02/08/2024 | 822.20 | 826.00 | 807.97 | 807.97 | 2,486,017 | |
| 02/07/2024 | 813.50 | 827.50 | 799.00 | 816.31 | 3,769,135 | |
| 02/06/2024 | 820.00 | 825.40 | 806.50 | 807.68 | 3,908,499 | |
| 02/05/2024 | 789.00 | 821.80 | 783.40 | 804.00 | 4,226,296 | |
| 02/02/2024 | 790.00 | 790.00 | 773.90 | 775.81 | 3,407,600 | |
| 02/01/2024 | 790.20 | 795.70 | 774.30 | 780.77 | 3,625,389 | |
| 01/31/2024 | 767.00 | 793.50 | 743.20 | 769.25 | 8,251,272 | |
| 01/30/2024 | 752.00 | 756.50 | 742.84 | 742.84 | 2,909,230 | |
| 01/29/2024 | 740.00 | 746.90 | 735.00 | 740.36 | 2,743,870 | |
| 01/26/2024 | 720.00 | 733.00 | 719.90 | 726.76 | 2,277,119 | |
| 01/25/2024 | 729.50 | 729.50 | 718.72 | 718.72 | 1,814,263 | |
| 01/24/2024 | 725.00 | 730.10 | 719.81 | 719.81 | 1,753,719 | |
| 01/23/2024 | 724.30 | 724.30 | 703.60 | 715.94 | 3,060,561 | |
| 01/22/2024 | 732.40 | 733.40 | 721.40 | 721.40 | 1,870,983 |
About Novo Nordisk Stock history
Novo Nordisk investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novo Nordisk AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novo Nordisk stock prices may prove useful in developing a viable investing in Novo Nordisk
Novo Nordisk AS, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Novo Nordisk operates under Pharmaceuticals And Biosciences classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 45971 people.
Novo Nordisk Stock Technical Analysis
Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Novo Nordisk Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novo Nordisk's price direction in advance. Along with the technical and fundamental analysis of Novo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.115 | |||
| Jensen Alpha | 0.287 | |||
| Total Risk Alpha | 0.1664 | |||
| Sortino Ratio | 0.1935 | |||
| Treynor Ratio | 2.05 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |